| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d7e2f8fb5650d7d3616661464b67771 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 |
| filingDate |
2019-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_602baf2bbad1cbf64aa14e53ce755a84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8082314c2c32f471c686eacf8fa9bbf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eeb1bef21626a7e7a93fbbf86de0b253 |
| publicationDate |
2020-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111643503-A |
| titleOfInvention |
Quinoline derivatives for the treatment of non-small cell lung cancer |
| abstract |
The application belongs to the field of medicine and provides a quinoline derivative for the treatment of non-small cell lung cancer, in particular to 1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yl) Use of oxy-6-methoxyquinolin-7-yl]oxy]methyl]cyclopropylamine combined with small molecule targeted antitumor drugs in the treatment of non-small cell lung cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114642728-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112316149-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115245514-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113116895-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113116895-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111620881-A |
| priorityDate |
2019-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |